These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26718161)

  • 1. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Diet and Lifestyle Management.
    Campbell KL; Rangan GK; Lopez-Vargas P; Tong A
    Semin Nephrol; 2015 Nov; 35(6):572-581.e17. PubMed ID: 26718161
    [No Abstract]   [Full Text] [Related]  

  • 2. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Psychosocial Care.
    Tong A; Mallett A; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):590-594.e5. PubMed ID: 26718163
    [No Abstract]   [Full Text] [Related]  

  • 3. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Polycystic Liver Disease.
    Savige J; Mallett A; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):618-622.e5. PubMed ID: 26718168
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Monitoring Disease Progression.
    Mai J; Lee VW; Lopez-Vargas P; Vladica P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):565-571.e18. PubMed ID: 26718160
    [No Abstract]   [Full Text] [Related]  

  • 6. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Intracranial Aneurysms.
    Lee VW; Dexter MA; Mai J; Vladica P; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):612-617.e20. PubMed ID: 26718167
    [No Abstract]   [Full Text] [Related]  

  • 7. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of Renal Stone Disease.
    Mallett A; Patel M; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):603-606.e3. PubMed ID: 26718165
    [No Abstract]   [Full Text] [Related]  

  • 8. KHA-CARI Autosomal Dominant Kidney Disease Guideline: Management of Chronic Pain.
    Savige J; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):607-611.e3. PubMed ID: 26718166
    [No Abstract]   [Full Text] [Related]  

  • 9. Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented?
    Davis ID; MacRae Dell K; Sweeney WE; Avner ED
    Semin Nephrol; 2001 Sep; 21(5):430-40. PubMed ID: 11559884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.
    Rangan GK; Alexander SI; Campbell KL; Dexter MA; Lee VW; Lopez-Vargas P; Mai J; Mallett A; Patel C; Patel M; Tchan MC; Tong A; Tunnicliffe DJ; Vladica P; Savige J
    Nephrology (Carlton); 2016 Aug; 21(8):705-16. PubMed ID: 26511892
    [No Abstract]   [Full Text] [Related]  

  • 11. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
    Lee VW; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):595-602.e12. PubMed ID: 26718164
    [No Abstract]   [Full Text] [Related]  

  • 12. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Pharmacological Management.
    Mallett A; Lee VW; Mai J; Lopez-Vargas P; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):582-589.e17. PubMed ID: 26718162
    [No Abstract]   [Full Text] [Related]  

  • 13. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Screening for Polycystic Kidney Disease.
    Rangan GK; Lee VW; Alexander SI; Patel C; Tunnicliffe DJ; Vladica P
    Semin Nephrol; 2015 Nov; 35(6):557-564.e6. PubMed ID: 26718159
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction to the KHA-CARI Guidelines on ADPKD.
    Rangan GK; Savige J
    Semin Nephrol; 2015 Nov; 35(6):521-3. PubMed ID: 26718154
    [No Abstract]   [Full Text] [Related]  

  • 15. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Imaging Approaches for Diagnosis.
    Mai J; Lee VW; Lopez-Vargas P; Vladica P
    Semin Nephrol; 2015 Nov; 35(6):538-544.e17. PubMed ID: 26718156
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease.
    Steele CN; Nowak KL
    Adv Kidney Dis Health; 2023 May; 30(3):220-227. PubMed ID: 37088524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Niemczyk M; Pilecki T; Gradzik M; Bujko M; Niemczyk S; Pączek L
    Kidney Blood Press Res; 2014; 39(6):630-5. PubMed ID: 25571876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Genetic Testing for Diagnosis.
    Tchan M; Savige J; Patel C; Mallett A; Tong A; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):545-549.e2. PubMed ID: 26718157
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuts, hypertension and endothelial function.
    Casas-Agustench P; López-Uriarte P; Ros E; Bulló M; Salas-Salvadó J
    Nutr Metab Cardiovasc Dis; 2011 Jun; 21 Suppl 1():S21-33. PubMed ID: 21546229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of autosomal dominant polycystic kidney disease.
    Grünfeld JP; Bennett WM
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):114-20. PubMed ID: 7600041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.